首页>
外国专利>
NOVEL LUNG CANCER CELL LINE DERIVED FROM A PATIENT, AND A KIT CONTAINING THE SAME FOR SCREENING A LUNG CANCER THERAPEUTIC AGENT
NOVEL LUNG CANCER CELL LINE DERIVED FROM A PATIENT, AND A KIT CONTAINING THE SAME FOR SCREENING A LUNG CANCER THERAPEUTIC AGENT
展开▼
机译:源自患者的新型肺癌细胞系,以及包含相同筛查肺癌治疗剂的试剂盒
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A novel lung cancer cell line and a kit containing the same for screening a lung cancer therapeutic agent are provided to ensure the trait of lung cancer cells and to develop a customized therapeutic agent.;CONSTITUTION: A method for screening a lung cancer therapeutic agent comprises: a step of culturing a novel lung cancer cell line, SMC-L001(deposit number: KCLRF-BP-00274); a step of treating the lung cell line with a candidate material as a lung cancer therapeutic agent; a step of culturing the treated lung cancer cell line and measuring morphological, physiological, or genetic change of the lung cancer cell line; and a step of determining whether the candidate material is used as a lung cancer therapeutic agent. A kit for screening the lung cancer therapeutic agent contains the lung cancer cell line.;COPYRIGHT KIPO 2013
展开▼